Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose ...

Semaglutide, the active ingredient in medications like Ozempic and Wegovy, shows promise as a treatment for alcohol addiction ...

Diabetes doesn’t just coexist with heart disease - it actively reshapes the heart’s machinery and the way it makes energy.

Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...

The lowest doses of the daily pill will cost $149 a month for people paying out of pocket, offering a cheaper alternative to ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 ...

HAPPY New Year! Now feels like a good time to introduce myself to any new recruits, and remind readers I’m here to help. As ...

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing ...

Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss ...

Danish drug maker Novo Nordisk is preparing to introduce a new version of its blockbuster drug Ozempic to compete with ...

A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from ...